SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001387131-18-006826
Filing Date
2018-12-18
Accepted
2018-12-18 17:02:30
Documents
7
Period of Report
2019-01-18
Effectiveness Date
2018-12-18

Document Format Files

Seq Description Document Type Size
1 DEFINITIVE PROXY STATEMENT ohr-def14a_011819.htm DEF 14A 230289
2 GRAPHIC proxycard_img001.jpg GRAPHIC 3297
3 GRAPHIC proxycard_img002.jpg GRAPHIC 1683
4 GRAPHIC proxycard_img003.jpg GRAPHIC 970
5 GRAPHIC proxycard_img004.jpg GRAPHIC 960
6 GRAPHIC proxycard_img005.jpg GRAPHIC 495
7 GRAPHIC ohr-def14a_img001.jpg GRAPHIC 6412
  Complete submission text file 0001387131-18-006826.txt   251483
Mailing Address 800 THIRD AVENUE 11TH FLOOR NEW YORK NY 10022
Business Address 800 THIRD AVENUE 11TH FLOOR NEW YORK NY 10022 (212) 682-8452
Ohr Pharmaceutical Inc (Filer) CIK: 0001173281 (see all company filings)

IRS No.: 465622433 | State of Incorp.: DE | Fiscal Year End: 0930
Type: DEF 14A | Act: 34 | File No.: 001-35963 | Film No.: 181241166
SIC: 2834 Pharmaceutical Preparations